A payer armed with this knowledge can refuse to pay exorbitant prices or large rebates for a drug in the final years of its patent life, knowing that a cheap alternative is on the horizon
Moreover, in light of the growing evidence demonstrating the benefits of incretin-based therapies on both metabolic health and cardiovascular diseases, regulatory agencies such as the Food Drug Administration (FDA) and the European Medicines Agency (EMA) have approved their use for type 2 diabetes, reduction of cardiovascular risk and for chronic weight management in patients with morbid obesity [5,6,7,8]
We find that patients benefit from at least a 12-month comprehensive weight-loss program to establish the proper habits to sustain long-term weight loss If you are not a good candidate for GLP-1 agonists, our physicians will offer different modalities of weight loss for you, including alternative medications, lifestyle modification, continuous glucose monitoring, and other tools that we use as a part of our weight loss program in Roslyn, New York
Resistance training helps preserve muscle mass during weight loss, which is particularly important for maintaining metabolic rate
.jpg)
